Thursday, May 27, 2010

Alexza Gets $25M In Financing Facility

Mountain View-based Alexza Pharmaceuticals, a publicly held firm focused on treatment of central nervous system conditions, said today it has received a committed equity financing facility worth $25M. The funding comes from Azimuth Opporunity, Ltd., over a 24-month period. The firm said the equity will allow it to raise capital as needed, and that it will determine the timing, dollar amount, and floor price of each draw from the facility.